OFIX Orthofix Medical Inc. logo

OFIX Orthofix Medical Inc.

Healthcare
$10.75+3.27%ClosedMarket Cap: $434.5M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

PEG

P/B

1.00

P/S

0.53

EV/EBITDA

5.72

DCF Value

$-87.49

FCF Yield

-0.8%

Div Yield

0.0%

Margins & Returns

Gross Margin

69.0%

Operating Margin

-4.0%

Net Margin

-7.3%

ROE

-13.4%

ROA

-6.8%

ROIC

-4.6%

Financials

View All
PeriodRevenueNet IncomeEPS
Q1 null$196.7M$-20.9M$
Q4 null$219.9M$-2.2M$
FY null$822.3M$-92.2M$
Q3 null$205.6M$-22.8M$

Analyst Ratings

View All

Consensus

Hold

Target (Consensus)

$15.60

Target (Median)

$15.00

Target Range

$12.00 - $18.00

1 Strong Buy2 Buy2 Hold0 Sell0 Strong Sell
Canaccord GenuityBuy
2026-05-22
Barrington ResearchOutperform
2026-05-22
StifelBuy
2026-05-22
Barrington ResearchOutperform
2026-04-10
StifelBuy
2026-03-09

Trading Activity

Insider Trades

View All
HENNEMAN JOHN B IIIdirector
BuyFri May 08
Engine Capital Management, LP10 percent owner
BuyThu May 07
Engine Capital Management, LP10 percent owner
BuyThu May 07
Engine Capital Management, LP10 percent owner
BuyThu May 07
Engine Capital Management, LP10 percent owner
BuyThu May 07

Company Info

Sector

Healthcare

Industry

Medical - Devices

Country

US

Exchange

Beta

0.79

Orthofix Medical Inc. operates as a medical device and biologics company in the United States, Italy, Germany, France, the United Kingdom, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion, as well as used as a therapeutic treatment for non-spinal and appendicular fractures. This segment also designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and a portfolio of products and tissue forms that allow physicians to treat a range of spinal and orthopedic conditions, as well as markets regenerative non-tissue biologic solutions derived from synthetic materials. The Global Orthopedics segment designs, develops, and markets orthopedic products that are used in fracture repair, deformity correction, and bone reconstruction procedures. The company markets and distributes its products through direct sales representatives; independent distributors; and employed and independent sales representatives to physicians, hospitals, ambulatory surgery centers, integrated health delivery systems, and other purchasing organizations. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in July 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.

Peers